Kwadwo Agyei-gyamfi, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4348 Fayetteville Rd, Lumberton, NC 28358 Phone: 910-739-2519 Fax: 910-739-5294 |
Santhosh Augustine, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 101 W 27th St, Lumberton, NC 28358 Phone: 910-739-0770 Fax: 910-739-4102 |
Gregory Locklear, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1011 Woodridge Dr, Lumberton, NC 28358 Phone: 910-739-8825 Fax: 910-739-8823 |
News Archive
A new study indicates that the topoisomerase 1 (Top1) is intimately related to the lethal inflammation associated with SARS-CoV-2 infection in a large proportion of cases.
Cancer researchers at the University of Calgary are investigating a new tool to use for the prognosis of breast cancer in patients. This new digital tool will help give patients a more accurate assessment of how abnormal and aggressive their cancer is and help doctors recommend the best treatment options.
The doors are closing on the AIDS virus. The scientific community continues to strive to find the formula that will halt the advance of one of the viruses that has sparked most scientific interest over recent years. A study by the Consejo Superior de Investigaciones Cient-ficas (CSIC) and led by Mr F-lix Go-i, director of the Biophysics Unit at the CSIC-University of the Basque Country Mixed Centre, has developed a method of attack against the AIDS virus The method involves creating a prevention system, i.e. an 'armour' in the cells that are likely to be infected and thus impede, de facto, the virus from accessing them and starting to act on their immunological system.
Nutraceutical International Corporation today reported results for the fiscal 2010 second quarter ended March 31, 2010. Net sales for the fiscal 2010 second quarter were $47.9 million compared to $42.0 million for the same quarter of fiscal 2009. For the second quarter of fiscal 2010, net income was $5.1 million, or $0.49 diluted earnings per share, compared to a net loss of $(23.4) million, or $(2.15) per diluted share, for the same quarter of fiscal 2009.
› Verified 6 days ago